The planar molecules of the title compound, C 15 H 13 FO 2 , are normal. The non-centrosymmetric crystal packing may be influenced by weak C-HÁ Á ÁO and C-HÁ Á ÁF interactions.
4-Fluorophenyl 4-{1,1,1,3,3,3-hexafluoro-2-[4-(4-fluorobenzoyl)phenyl]-2-propyl}phenyl ketone
✍ Scribed by Rodríguez de Barbarín, Cecilia ;Bernès, Sylvain ;Macossay, Javier ;Cassidy, Patrick E.
- Publisher
- International Union of Crystallography
- Year
- 2006
- Tongue
- English
- Weight
- 187 KB
- Volume
- 62
- Category
- Article
- ISSN
- 1600-5368
No coin nor oath required. For personal study only.
✦ Synopsis
Single-crystal X-ray study T = 298 K Mean (C-C) = 0.005 A R factor = 0.056 wR factor = 0.161 Data-to-parameter ratio = 12.5 For details of how these key indicators were automatically derived from the article, see http://journals.iucr.org/e.
📜 SIMILAR VOLUMES
In the title compound, C 18 H 17 FO 4 , the dihedral angle between the benzene rings is 12.42 (2) . The crystal structure is stabilized by C-HÁ Á ÁO, C-HÁ Á Á andinteractions.
In the title __N__,__S__-substituted compound, C~20~H~16~Cl~4~FN~3~O~2~S, the piperazine ring adopts a chair conformation. The butadiene unit assumes a configuration close to __cisoid__.
In the title biologically active compound, C 17 H 13 Cl 2 FO 3 , the central C C double bond is trans configured. The molecule consists of two essentially planar parts which are twisted by 67.06 (2) with respect to each other.